The purpose of this study was to determine the effects of phytosterol esterenriched vegetable oil on the serum concentration of cholesterol and to assess its safety in healthy subjects with normocholesterolemics. Twenty-two healthy subjects completed this study in a double blind, parallel arm design. The subjects were randomly divided into 2 groups: control group (n = 11) and phytosterol ester-enriched group (n = 11), and fed either 42 g of phytosterol ester-enriched vegetable oil or control vegetable oil, containing about 1.336 g and 0.117 g of phytosterol (as the major free sterol) respectively, daily for 4 weeks. Serum lipids, apolipoproteins, serum fat-soluble vitamins, serum phytosterols and biochemical parameters were measured. The subjects were asked to report any side effect. Phytosterol ester-enriched vegetable oil significantly reduced the concentrations of serum total cholesterol, low-density lipoprotein cholesterol and apolipoprotein B, by 3.3%, 4.4% and 3.2% respectively, compared with control oil. No significant changes were found in the concentrations of triacylglycerol, high-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, remnant-like lipoprotein cholesterol and other kinds of apolipoproteins. Neither vegetable oil affected the concentrations of fat-soluble vitamins (retinol and a-tocopherol) or b-carotene. Serum bsitosterol and campesterol were significantly higher in the phytosterol ester-enriched vegetable oil group compared with the control oil group. The concentrations of biochemical parameters did not change in either group. There were no side effects or serious adverse events in either group during the administration. In conclusion, the results showed that a daily 1.336 g intake of phytosterol (as the major free sterol) is effective in lowering serum total-and LDL-cholesterol in healthy men and has no negative physiologic action.
Introduction
Elevated serum concentrations of cholesterol are a major risk factor for the development of coronary heart disease (CHD) (1) . Mildly hypercholesterolemic persons usually have dietary guidelines prescribed as the first treatment to lower their serum cholesterol concentration. Normocholesterolemic persons may follow such a diet as part of a healthy lifestyle. For example, dietary factors contributing significantly to a reduction of serum total cholesterol include high concentrations of linoleic acid and low concentrations of saturated fatty acids (2) (3) (4) . The serum cholesterol-reducing effects of phytosterol have been well known since the 1950s (5-13) as well as factors derived from foods (2) (3) (4) . The amount of phytosterols obtained from food sources is generally small, ranging from 0.1 to 0.5 g/day (14) (15) . At these levels of consumption, phytosterol may not have a substantial impact on the serum concentrations of cholesterol; consequently, enriching food products with plant sterol or stanol would contribute to reduce serum cholesterol (13, 16) . Phytosterols exist in vegetable oil as free sterol or sterol ester with fatty acid. Esterification of phytosterols with fatty acids makes them more fat-soluble (17) , allowing an effective amount to be incorporated into a relatively small quantity of fat-containing food with the goal of reducing serum cholesterol (17) (18) .
We found that a daily intake of 14 g/day phytosterol enriched-vegetable oil containing 0.445 g phytosterol (as the major free sterol) reduced serum total cholesterol in healthy subjects with mildly elevated serum concentrations of total cholesterol (19) . This study examines the effects of a daily intake of 42 g/day phytosterol ester-enriched vegetable oil, on the concentrations of serum lipids, fat-soluble vitamins, serum phytosterols and biochemical parameters in healthy normocholesterolemic subjects.
Methods 1 Subjects
Twenty-two normocholesterolemic healthy men participated in this clinical trial. Their ages were between 21 and 58 (mean ± SD:41.1 ± 11.3) years. Their serum total cholesterol was from 181 to 198 mg/dL and triacylglycerol was less than 200 mg/dL. The subjects answered a family history questionnaire to screen them for familial hyperlipidemia, diabetes, hypothyroidism, hypertension and heart disease. Individuals who had been on drug therapy for hyperlipidemia during the previous 2 months were excluded. The study was carried out in accordance with the Helsinki declaration of 1964 (revised in 2000) and was approved by the Ethics Committee of Ochanomizu University. The procedures were explained in detail to all the volunteers in advance. Signed written informed consent was obtained from all the volunteers before participating in this study.
Protocol and Study Product
This study was conducted in a randomized, doubleblind and placebo-controlled parallel arm design. The total period of this study was 6 weeks, consisting of a 2-week wash-out period and a 4-week administration period. All subjects consumed a control diet (bread including 42 g of control oil) during the wash-out period to familiarize them with the study product. After 2-week familiarization, the subjects were randomly assigned to each treatment group at week 0 before the start of the administration. After the wash-out period, the subjects were provided with bread containing 42 g of either phytosterol ester-enriched vegetable oil or control vegetable oil. Each vegetable oil contained 1.336 g and 0.117 g phytosterol (as the major free sterol) in 42 g vegetable oil, respectively. All subjects consumed bread from 2 to 3 times per day. Phytosterol esterenriched vegetable oil was prepared by the following method. First, esterification of phytosterol was carried out by enzymatic transesterification of phytosterol (10%, w/w) and refined rapeseed oil (90%, w/w). Second, the above vegetable oil, including much phytosterol ester, was refined by the common method used for edible vegetable oil. Finally, phytosterol esterenriched vegetable oil was prepared by blending 3 kinds of vegetable oil: 25 g of the enzymatically esterified oil, 15 g of refined rapeseed oil and 60 g of refined rice oil. The sterol composition is shown in Table 1 .
Effects of Phytosterol Ester on Serum Cholesterol and Assessment of Safety
Major plant sterols in the phytosterol ester-enriched vegetable oil were b-sitosterol, campesterol, stigmasterol and brassicasterol.
3 Measurements
Blood samples were collected after fasting (>12 hr) on weeks -2, 0, 2 and 4. The subjects also underwent complete physical examinations and urine analysis on the same day. Analyses of serum total cholesterol and triacylglycerol were carried out using a 7450 Hitachi automated system (Hitachi, Tokyo, Japan). Analyses of VLDL-C, LDL-C and HDL-C were carried out using a rapid electrophoresis scanning (REP) automated system (Helena Laboratories, Saitama, Japan) by agarose-gel electrophoresis methods (20) . Apolipoproteins concentrations were measured nephelometrically using the Behring laser nephelometer (Behringwerke AL, Macburg, Germany) with specific antibodies against each human apolipoprotein. Serum concentrations of fat-soluble vitamins (a-tocopherol and retinol), bcarotene and phytosterols (b-sitosterol, campesterol, stigmasterol, brassicasterol and others) were measured by high-performance liquid chromatography (HPLC).
4 Statistical Analysis
Statistical analysis was performed using SPSS for WINDOWS (version 10.0j; SPSS Japan Inc., Tokyo). The results are presented as mean values ± SD. P values less than 0.05 were considered to indicate statistical significance. Differences of the measured values in anthropometric measurements, serum lipids, apolipoproteins, serum vitamins and serum phytosterols between the 2 groups were compared by repeated-measures analysis of variance (two-way ANOVA), KruskalWallis test and chi-square test as appropriate. When a significant difference was observed, comparison of measured values, changes in values and relative change rate was performed using Student's t-test or Wilcoxon rank-sum test.
5 Diet Records
Subjects were asked to complete a dietary record every day during the administration. All subjects were also provided with thorough instructions regarding dietary records before the start of the study. Dietary records were collected and analyzed by the dietitian based on the 5th Revision of the Standard Tables of Food Composition in Japan. The data on nutrients intake are shown in Table 2 . No significant difference was found between the 2 groups in all selected nutrients. 459.5 ± 9.6 14.4 ± 1.0 2.4 ± 0.3 1048.9 ± 107. 7 17.2 ± 0.5 1) There was no significant difference between the 2 groups.
2) All measurements are presented as the mean value ± SD. 3) REQ: retinol equivalents. 4) Total vitamin E: Total of a-, b-, g-and d-tocopherol.
Results

1 Subjects
After the screening process, 22 men completed the intervention period. Baseline characteristics are shown in Table 3 . Baseline characteristics in the phytosterol ester-enriched group were not significantly different from those in the control group.
The mean change rate of body weight was within the range of ± 2.0% in both groups, and showed no significant difference between the 2 groups. Blood pressure did not change either during the intervention period.
2 Serum Lipids and Apolipoproteins
The concentrations of serum cholesterol and serum triacylglycerol are shown in Table 4 and Table 5 . Baseline (week 0) serum cholesterol concentrations were similar between the 2 groups. Phytosterol esterenriched vegetable oil significantly reduced serum total-and LDL-cholesterol, by 3.3% and 4.4% respectively, compared to the control oil. The responses of VLDL-cholesterol, HDL-cholesterol and RLP-cholesterol did not significantly differ between the 2 groups. Triacylglycerol tended to decrease in both groups. There was, however, no significant change in triacylglycerol between the two groups. The concentrations of apolipoproteins are shown in Table 6 . Apo B in the phytosterol ester-enriched vegetable oil group significantly decreased compared with that in the control group. Other apolipoproteins showed no significant changes.
Serum Vitamins and Sterols
The concentrations of fat-soluble vitamins (retinol and a-tocopherol), b-carotene and phytosterols are shown in Table 7 . Serum concentrations of vitamins and carotene were within normal reference ranges at baseline and following 4 weeks of intervention in both groups. There were no significant differences in the concentrations of vitamins and carotene at baseline or week 4 between the 2 groups. The concentrations of serum b-sitosterol and campesterol in the phytosterol ester-enriched vegetable oil group showed significant increases compared with those in the control group. Stigmasterol was not detected (the lowest concentration of detection = 1.0 mg/mL).
4 Blood Biochemical Parameters and
Side Effects Results of biochemical analyses are presented in Table 8 . No parameter showed a significant change in either group, except for constipation in two subjects during the treatment period. There were no changes in hematological parameters either (data not shown).
Discussion
This study confirmed the substantial serum total-and LDL-cholesterol lowering effect of the daily phytosterol administration at 1.336 g/day (as the major free sterol) for 4 weeks. Serum total-and LDL-cholesterol decreased by 3.3% and 4.4%, respectively. Additionally, there were no obvious product-related adverse events nor were there any changes in the concentrations of fat- 2) There was no significant difference between the 2 groups in any parameter. 3) Abbreviations: PS, phytosterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; g-GTP, gammaglutamyltranspeptidase; LDH, lactic dehydrogenase. 2) All measurements are presented as the mean value ± SD.
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3) There was no significant difference between the 2 groups in any parameter at any determination point.
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3) **: P<0.01 versus control by two-way ANOVA regarding measurements at each determination point (weeks 0, 2, 4). ##: P<0.01
versus control (by student's t-test).
Table 7
Serum Concentrations of Vitamins and Phytosterols at Week 0 and Week 4.
Baseline (week 0) 3) **: (P<0.01) versus control (two-way ANOVA). #: (P<0.05) versus control (student's t-test). : (P<0.05) versus baseline (student's t-test).
: (P<0.01) versus baseline (student's t-test)
soluble vitamins, b-carotene and biochemical parameters. The only significant changes were increases in serum b-sitosterol and campesterol. Previous studies (6, 16, (21) (22) (23) (24) , which analyzed the change of serum cholesterol in subjects with normal baseline serum total cholesterol, did not show a fixed trend of response to phytosterol intake. Judd et al. (22) reported that the baseline concentration was a significant predictor of the final concentration for all serum lipids and lipoproteins, and that the magnitude of change in serum lipids was the same over all baseline concentrations. Westrate et al. (6) also reported that the percentage size of the effect was the same in normocholesterolemic subjects and mildly hypercholesterolemic subjects. That is, the effect of treatment on a serum lipid or lipoprotein is independent of the baseline concentration. In the current study, in which subjects had normal total-or LDL-cholesterol concentrations at baseline, the total-cholesterol in the phytosterol esterenriched vegetable oil group decreased significantly by 3.3 ± 5.8% compared with that in the control group. As for its safety, 42 g intake of phytosterol ester-enriched vegetable oil seems safe and beneficial for healthy men.
Since phytosterols have high lipophilicity, phytosterol ester-enriched vegetable oil is expected to affect the absorption of fat-soluble vitamins and carotene. This effect has not been yet fully characterized, and there have been no reports of clinical problems (6, 8, 16, (25) (26) (27) . Lower serum a-tocopherol concentrations following phytosterol consumption have been reported (26) ; however, this was not an unexpected finding since most tocopherol is carried in LDL particles, which also decrease by phytosterol consumption. In fact, the ratio of a-tocopherol to serum total cholesterol did not significantly change. In the current study, serum concentrations of fat-soluble vitamins and bcarotene remained within normal references values. There was no difference in serum vitamins and bcarotene responses between the 2 groups. This finding was similar to those of previous studies (21) (22) (23) (27) (28) .
The group receiving phytosterol ester-enriched vegetable oil showed significant increases in serum b-sitosterol and campesterol. The results of the current study are in agreement with other studies conducted to date (6, 27) . In patients with sitosterolemia, the concentrations of serum total phytosterols are in the range of 10 to 60 mg/dL, whereas under normal circumstances, total phytosterol concentrations in blood are generally reported to be less than 1 mg/dL (29) . The mean bsitosterol and campesterol concentrations in the current study were 2.0 ± 0.9 and 3.2 ± 1.4 mg/mL respectively. Therefore, these concentrations were within the normal range.
The safety information available from clinical trials involving hypercholesterolemic patients suggests, in general, that phytosterol is well tolerated with no reported side effects regarding blood biochemical parameters and hematological variables (16 2) All measurements are presented as the mean value ± SD.
3) There was no significant difference between the 2 groups in any parameter at any determination point. 4) Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; g-GTP, gamma-glutamyltranspeptidase; ALP, alkaline phosphatase; BUN, blood urea nitrogen; HbA1c, hemoglobin A1c.
conducted in children with severe hypercholesterolemia also indicate a favorable safety profile for phytosterols (8) . In the current study involving normocholesterolemic subjects, there were neither obvious side events nor abnormal changes of biochemical parameters in the 2 groups. These results are in agreement with those of other studies (6, 8, 16, 27 ) that indicate phytosterol-containing foods are safe.
Our previous study has shown that a daily intake of 14 g/day phytosterol ester-enriched vegetable oil containing 0.445 g phytosterol (as the major free sterol) reduced serum total cholesterol in healthy subjects with mildly elevated serum concentrations of total cholesterol (19) . In conclusion, the results in this present paper indicate that a daily intake of 42 g/day phytosterol ester-enriched vegetable oil containing 1.336 g phytosterol (as the major free sterol) have no negative physiologic action with respect to serum fat-soluble vitamins, carotenoids, or biochemical parameters and may lower the risk of atherosclerosis in healthy men with normal serum concentrations of cholesterol.
